MA26216A1 - Nouveaux composes - Google Patents

Nouveaux composes

Info

Publication number: MA26216A1
Authority: MA; Morocco
Prior art keywords: new compounds; compounds; new
Prior art date: 2001-09-13

Application number

MA27573A

Other languages

English (en)

Inventor

Harshad Kantilal Rami

Mervyn Thompson

Paul Adrian Wyman

Original Assignee

Smithkline Beecham Plc

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2001-09-13

Filing date

2004-03-12

Publication date

2004-07-01

2001-09-13 Priority claimed from GB0122156A external-priority patent/GB0122156D0/en

2001-12-20 Priority claimed from GB0130505A external-priority patent/GB0130505D0/en

2001-12-20 Priority claimed from GB0130547A external-priority patent/GB0130547D0/en

2001-12-20 Priority claimed from GB0130503A external-priority patent/GB0130503D0/en

2004-03-12 Application filed by Smithkline Beecham Plc filed Critical Smithkline Beecham Plc

2004-07-01 Publication of MA26216A1 publication Critical patent/MA26216A1/fr

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/08—Bronchodilators
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/10—Drugs for disorders of the urinary system of the bladder
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/04—Antipruritics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/12—Antidiuretics, e.g. drugs for diabetes insipidus
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Veterinary Medicine (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Animal Behavior & Ethology (AREA)
Pharmacology & Pharmacy (AREA)
Life Sciences & Earth Sciences (AREA)
Biomedical Technology (AREA)
Neurology (AREA)
Neurosurgery (AREA)
Pain & Pain Management (AREA)
Pulmonology (AREA)
Dermatology (AREA)
Cardiology (AREA)
Urology & Nephrology (AREA)
Diabetes (AREA)
Heart & Thoracic Surgery (AREA)
Hospice & Palliative Care (AREA)
Hematology (AREA)
Rheumatology (AREA)
Psychiatry (AREA)
Otolaryngology (AREA)
Vascular Medicine (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Plural Heterocyclic Compounds (AREA)
Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Hydrogenated Pyridines (AREA)

MA27573A 2001-09-13 2004-03-12 Nouveaux composes MA26216A1 (fr)

Applications Claiming Priority (4)

Application Number	Priority Date	Filing Date	Title
GB0122156A GB0122156D0 (en)	2001-09-13	2001-09-13	Novel compounds
GB0130505A GB0130505D0 (en)	2001-12-20	2001-12-20	Novel compounds
GB0130547A GB0130547D0 (en)	2001-12-20	2001-12-20	Novel compounds
GB0130503A GB0130503D0 (en)	2001-12-20	2001-12-20	Novel compounds

Publications (1)

Publication Number	Publication Date
MA26216A1 true MA26216A1 (fr)	2004-07-01

Family

ID=27447989

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
MA27573A MA26216A1 (fr)	2001-09-13	2004-03-12	Nouveaux composes

Country Status (32)

Country	Link
US (1)	US8063078B2 (fr)
EP (3)	EP2036902A3 (fr)
JP (2)	JP4463552B2 (fr)
KR (3)	KR20100082390A (fr)
CN (1)	CN1247568C (fr)
AP (1)	AP1818A (fr)
AR (1)	AR038786A1 (fr)
AT (1)	ATE420083T1 (fr)
AU (1)	AU2002329397B2 (fr)
BR (1)	BR0212468A (fr)
CA (1)	CA2458632C (fr)
CY (1)	CY1109449T1 (fr)
DE (1)	DE60230773D1 (fr)
DK (1)	DK1425277T3 (fr)
EA (1)	EA007731B1 (fr)
ES (1)	ES2316607T3 (fr)
HK (1)	HK1066534A1 (fr)
HU (1)	HUP0401923A3 (fr)
IL (2)	IL160755A0 (fr)
MA (1)	MA26216A1 (fr)
MX (1)	MXPA04002379A (fr)
MY (1)	MY138086A (fr)
NO (3)	NO327009B1 (fr)
NZ (1)	NZ531137A (fr)
OA (1)	OA12659A (fr)
PE (1)	PE20030417A1 (fr)
PL (1)	PL213639B1 (fr)
PT (1)	PT1425277E (fr)
SI (1)	SI1425277T1 (fr)
TW (1)	TWI283665B (fr)
UY (1)	UY27446A1 (fr)
WO (1)	WO2003022809A2 (fr)

Families Citing this family (50)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
PE20030417A1 (es)	2001-09-13	2003-08-06	Smithkline Beecham Plc	Derivados de urea como antagonistas del receptor vainilloide
ATE465993T1 (de)	2002-02-01	2010-05-15	Euro Celtique Sa	2-piperazinpyridine für die schmerzbehandlung
CA2476936A1 (fr) *	2002-02-20	2003-08-28	Chih-Hung Lee	Composes azabicycliques fusionnes qui inhibent le recepteur (vr1) sous-type 1 du recepteur vanilloide
US7074805B2 (en)	2002-02-20	2006-07-11	Abbott Laboratories	Fused azabicyclic compounds that inhibit vanilloid receptor subtype 1 (VR1) receptor
US6974818B2 (en)	2002-03-01	2005-12-13	Euro-Celtique S.A.	1,2,5-thiadiazol-3-YL-piperazine therapeutic agents useful for treating pain
WO2004002983A2 (fr)	2002-06-28	2004-01-08	Euro-Celtique, S.A.	Agents therapeutiques utiles pour le traitement de la douleur
US7262194B2 (en)	2002-07-26	2007-08-28	Euro-Celtique S.A.	Therapeutic agents useful for treating pain
GB0221157D0 (en) *	2002-09-12	2002-10-23	Glaxo Group Ltd	Novel treatment
WO2004024710A1 (fr) *	2002-09-13	2004-03-25	Glaxo Group Limited	Composes a base d'uree, actifs en tant qu'antagonistes du recepteur de la vanilloide et utilises pour traiter les douleurs
US7157462B2 (en)	2002-09-24	2007-01-02	Euro-Celtique S.A.	Therapeutic agents useful for treating pain
EP1569896B1 (fr)	2002-12-06	2007-08-15	Bayer HealthCare AG	Derives de tetrahydro-naphthalene
GB0229808D0 (en)	2002-12-20	2003-01-29	Glaxo Group Ltd	Novel compositions
US6933311B2 (en) *	2003-02-11	2005-08-23	Abbott Laboratories	Fused azabicyclic compounds that inhibit vanilloid receptor subtype 1 (VR1) receptor
ATE440835T1 (de)	2003-03-06	2009-09-15	Glaxo Group Ltd	Heterozyklische harnstoff-derivate für die behandlung von schmerzen.
US7514562B2 (en)	2003-03-07	2009-04-07	Glaxo Group Limited	Urea derivatives and their use as vanilloid receptor antagonists in the treatment of pain
GB0305426D0 (en) *	2003-03-08	2003-04-16	Glaxo Group Ltd	Novel compounds
SE0301446D0 (sv)	2003-05-16	2003-05-16	Astrazeneca Ab	New Compounds
CA2526361C (fr)	2003-05-20	2012-05-15	Ajinomoto Co., Inc.	Derive d'amide
EP1493438A1 (fr) *	2003-07-03	2005-01-05	Bayer HealthCare AG	Inhibiteurs du recepteur vanilloide (VR1) dans le traitement de la douleur associée au VIH
GB0319150D0 (en)	2003-08-14	2003-09-17	Glaxo Group Ltd	Novel compounds
GB0319151D0 (en) *	2003-08-14	2003-09-17	Glaxo Group Ltd	Novel compounds
DE602004019294D1 (de) *	2003-10-01	2009-03-19	Xention Ltd	Tetrahydronaphthalin- und harnstoffderivate
JP4935073B2 (ja)	2003-10-14	2012-05-23	味の素株式会社	エーテル誘導体
CA2542494A1 (fr) *	2003-10-15	2005-05-06	Bayer Healthcare Ag	Derives de tetrahydro-naphthalene et d'uree
JP2007523888A (ja)	2003-11-08	2007-08-23	バイエル・ヘルスケア・アクチェンゲゼルシャフト	テトラヒドロ−キノリニル尿素誘導体
JP4775259B2 (ja) *	2004-03-31	2011-09-21	味の素株式会社	アニリン誘導体
EP1768954A4 (fr)	2004-06-24	2008-05-28	Incyte Corp	2-methylpropanamides et leur utilisation en tant que pharmaceutiques
US7879866B2 (en)	2004-07-19	2011-02-01	Dorte Xenia Gram	Inhibition of the activity of the capsaicin receptor in the treatment of obesity or obesity-related diseases and disorders
KR20060087386A (ko)	2005-01-28	2006-08-02	주식회사 대웅제약	신규 벤조이미다졸 유도체 및 이를 함유하는 약제학적조성물
WO2006098554A1 (fr) *	2005-03-16	2006-09-21	Amorepacific Corporation	Nouveaux composes, isomere de ceux-ci ou sels pharmaceutiquement acceptables de ceux-ci en tant qu’antagonistes du recepteur vanilloide ; et composition pharmaceutique contenant ceux-ci
WO2007046867A2 (fr) *	2005-05-19	2007-04-26	Xenon Pharmaceuticals Inc.	Derives de piperidine et leurs utilisations comme agents therapeutiques
TW200736227A (en)	2005-12-23	2007-10-01	Astrazeneca Ab	New compounds III
EP1889830A1 (fr) *	2006-07-10	2008-02-20	Pharmeste S.r.l.	Amides biarylcarboxyaryles en tant que modulateurs du recepteur vanilloid-1.
AR063211A1 (es) *	2006-07-27	2009-01-14	Amorepacific Corp	Derivados de 3-(piridin-3-il)acrilamida y 3-(piridin-3-il)propionamida, un metodo para su preparacion, una composicion farmaceutica que los comprende y su uso en la fabricacion de medicamentos para el tratamiento de enfermedades asociadas con el receptor vaniloide.
EP1882687A1 (fr) *	2006-07-27	2008-01-30	Amorepacific Corporation	Composés hétérocycliques, leur utilisation comme antagonistes du récepteur vanilloide et les compositions pharmaceutiques qui les contiennent
TWI433839B (zh)	2006-08-11	2014-04-11	Neomed Inst	新穎的苯并咪唑衍生物290
JP2010501592A (ja)	2006-08-25	2010-01-21	アボット・ラボラトリーズ	Ｔｒｐｖ１を阻害するインダゾール誘導体およびその使用
EP2450346A1 (fr)	2006-12-20	2012-05-09	Abbott Laboratories	Antagonistes du récepteur TRPV1 et utilisations associées
MX2010010262A (es)	2008-03-20	2010-12-06	Abbott Lab	Metodos para la elaboracion de agentes para el sistema nervioso central que son antagonistas del trpv1.
WO2009128661A2 (fr)	2008-04-18	2009-10-22	주식회사 대웅제약	Nouveau dérivé de benzoxazine benzimidazole, composition pharmaceutique le comprenant et application s'y rapportant
CN102089277B (zh) *	2008-05-07	2014-02-12	大日本住友制药株式会社	环状胺-1-甲酸酯衍生物及含有其的药物组合物
WO2010026128A1 (fr) *	2008-09-02	2010-03-11	Glaxo Group Limited	N-(3-méthyl-5-isoquinolinyl)-n'-((3r)-l-[5-(trifluorométhyl)-2-pyridinyl]-3-pyrrolidinyl) urée pour le traitement de la rhinite
EP2340023A1 (fr) *	2008-09-02	2011-07-06	Glaxo Group Limited	Antagoniste sb-705498 du récepteur trpvl pour le traitement de la rhinite
JP2013028536A (ja) *	2009-11-11	2013-02-07	Dainippon Sumitomo Pharma Co Ltd	環状アミン−１−カルボン酸エステル誘導体およびそれを含有する医薬組成物
WO2012045729A1 (fr)	2010-10-05	2012-04-12	Glaxo Group Limited	Dérivés d'imidazo[1,2-a]pyridine et de pyrazolo[1,5-a]pyridine en tant qu'antagonistes du trpv1
KR101293384B1 (ko)	2010-10-13	2013-08-05	주식회사 대웅제약	신규 피리딜 벤조옥사진 유도체, 이를 포함하는 약학 조성물 및 이의 용도
WO2012072512A1 (fr)	2010-11-29	2012-06-07	Glaxo Group Limited	Carboxamides de n-cyclo-butylimidazopyridine ou de n-cyclo-pyrazolopyridine comme antagonistes de trpv1
GB201101517D0 (en) *	2011-01-28	2011-03-16	Proximagen Ltd	Receptor antagonists
US8754101B2 (en)	2011-04-11	2014-06-17	Glaxo Group Limited	N-cyclobutyl-imidazopyridine-methylamine as TRPV1 antagonists
DE102022104759A1 (de)	2022-02-28	2023-08-31	SCi Kontor GmbH	Co-Kristall-Screening Verfahren, insbesondere zur Herstellung von Co-Kristallen

Family Cites Families (27)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US3424760A (en) *	1966-03-07	1969-01-28	Robins Co Inc A H	3-ureidopyrrolidines
US3424761A (en) *	1966-03-07	1969-01-28	Robins Co Inc A H	3-ureidopyrrolidines
GB1460389A (en)	1974-07-25	1977-01-06	Pfizer Ltd	4-substituted quinazoline cardiac stimulants
ATE113205T1 (de)	1988-06-17	1994-11-15	Procter & Gamble	Anwendung von vanillin-derivaten zur herstellung eines arzneimittels zur behandlung von herpes simplex-infektion.
HU206082B (en)	1988-12-23	1992-08-28	Sandoz Ag	Process for producing capsaicin derivatives and pharmaceutical compositions comprising such compounds
CA2017383A1 (fr)	1989-06-08	1990-12-08	Raymond R. Martodam	Utilisation de vanilloides pour le traitement des affections ou des troubles respiratoires
AU9079491A (en)	1990-11-27	1992-06-25	Procter & Gamble Company, The	Combinations of vanilloid compounds and phosphonate antiviral compounds for treatment of herpes infections
US5149704A (en) *	1991-05-03	1992-09-22	Abbott Laboratories	Platelet activating antagonists
CA2197364A1 (fr) *	1996-02-15	1997-08-16	Toshikazu Suzuki	Compose phenolique et methode de preparation
WO1999000128A1 (fr) *	1997-06-26	1999-01-07	Eli Lilly And Company	Agents antithrombotiques
AU8270898A (en) *	1997-06-26	1999-01-19	Eli Lilly And Company	Antithrombotic agents
JP2000080085A (ja)	1997-09-01	2000-03-21	Kyorin Pharmaceut Co Ltd	６，７−非対称ジ置換キノキサリンカルボン酸誘導体とその付加塩及びそれらの製造方法
DE60024785T2 (de)	1999-02-22	2006-09-14	Amorepacific Corp.	Vanilloid-analoge die resiniferatoxin-pharmacophore enthalten als wirksame vanilloid rezeptor agonisten und analgetika, zusammensetzungen und ihre verwendung
SK12832001A3 (sk)	1999-03-12	2002-01-07	Boehringer Ingelheim Pharmaceuticals, Inc.	Protizápalové látky, spôsob ich výroby, farmaceutický prostriedok s ich obsahom a ich použitie
EP1220836A2 (fr) *	1999-10-15	2002-07-10	Bristol-Myers Squibb Pharma Company	Amines benzyle cycloalkyle comme modulateurs de l'activite du recepteur de la chimiokine
JP2004525071A (ja)	2000-07-20	2004-08-19	ニューロジェンコーポレイション	カプサイシン受容体リガンド
NZ523882A (en)	2000-08-21	2004-11-26	Pacific Corp	Novel thiourea derivatives and the pharmaceutical compositions containing the same
KR100453078B1 (ko)	2000-08-21	2004-10-15	주식회사 태평양	신규 티오우레아 화합물 및 이를 함유하는 약제학적 조성물
EP1311477A4 (fr)	2000-08-21	2005-01-12	Pacific Corp	Nouveaux derives d'acide thiocarbamique et compositions pharmaceutiques contenant lesdits derives
JP2002080073A (ja)	2000-09-07	2002-03-19	Kyokuto Kobunshi Kk	電子レンジ用自動開孔袋
JP2002088073A (ja) *	2000-09-08	2002-03-27	Yamanouchi Pharmaceut Co Ltd	抗アンドロゲン剤
GB0110901D0 (en)	2001-05-02	2001-06-27	Smithkline Beecham Plc	Novel Compounds
PE20030417A1 (es) *	2001-09-13	2003-08-06	Smithkline Beecham Plc	Derivados de urea como antagonistas del receptor vainilloide
RU2005102004A (ru) *	2002-06-27	2005-10-20	Шеринг Акциенгезельшафт (De)	Замещенные хинолины как антагонисты рецептора ccr5
WO2004024710A1 (fr) *	2002-09-13	2004-03-25	Glaxo Group Limited	Composes a base d'uree, actifs en tant qu'antagonistes du recepteur de la vanilloide et utilises pour traiter les douleurs
GB0229808D0 (en)	2002-12-20	2003-01-29	Glaxo Group Ltd	Novel compositions
CA2563494A1 (fr)	2004-04-20	2005-11-03	Bayer Healthcare Ag	Derives d'uree utilises en tant qu'antagonistes du recepteur vanilloide (vr1)

2002
- 2002-09-11 PE PE2002000895A patent/PE20030417A1/es not_active Application Discontinuation
- 2002-09-11 MY MYPI20023391A patent/MY138086A/en unknown
- 2002-09-11 TW TW091120671A patent/TWI283665B/zh not_active IP Right Cessation
- 2002-09-12 UY UY27446A patent/UY27446A1/es not_active Application Discontinuation
- 2002-09-12 AR ARP020103454A patent/AR038786A1/es active IP Right Grant
- 2002-09-13 SI SI200230792T patent/SI1425277T1/sl unknown
- 2002-09-13 EA EA200400432A patent/EA007731B1/ru not_active IP Right Cessation
- 2002-09-13 CN CNB028177177A patent/CN1247568C/zh not_active Expired - Fee Related
- 2002-09-13 HU HU0401923A patent/HUP0401923A3/hu unknown
- 2002-09-13 US US10/489,277 patent/US8063078B2/en not_active Expired - Fee Related
- 2002-09-13 KR KR1020107014626A patent/KR20100082390A/ko not_active Application Discontinuation
- 2002-09-13 KR KR1020097003812A patent/KR100955967B1/ko not_active IP Right Cessation
- 2002-09-13 JP JP2003526885A patent/JP4463552B2/ja not_active Expired - Fee Related
- 2002-09-13 NZ NZ531137A patent/NZ531137A/en not_active IP Right Cessation
- 2002-09-13 BR BR0212468-8A patent/BR0212468A/pt not_active IP Right Cessation
- 2002-09-13 AU AU2002329397A patent/AU2002329397B2/en not_active Ceased
- 2002-09-13 AT AT02765023T patent/ATE420083T1/de active
- 2002-09-13 PT PT02765023T patent/PT1425277E/pt unknown
- 2002-09-13 MX MXPA04002379A patent/MXPA04002379A/es active IP Right Grant
- 2002-09-13 ES ES02765023T patent/ES2316607T3/es not_active Expired - Lifetime
- 2002-09-13 EP EP08172882A patent/EP2036902A3/fr not_active Withdrawn
- 2002-09-13 KR KR1020047003680A patent/KR101063679B1/ko not_active IP Right Cessation
- 2002-09-13 EP EP10179466A patent/EP2298757A3/fr not_active Withdrawn
- 2002-09-13 CA CA2458632A patent/CA2458632C/fr not_active Expired - Fee Related
- 2002-09-13 DK DK02765023T patent/DK1425277T3/da active
- 2002-09-13 EP EP02765023A patent/EP1425277B8/fr not_active Expired - Lifetime
- 2002-09-13 DE DE60230773T patent/DE60230773D1/de not_active Expired - Lifetime
- 2002-09-13 WO PCT/GB2002/004206 patent/WO2003022809A2/fr active Application Filing
- 2002-09-13 OA OA1200400070A patent/OA12659A/en unknown
- 2002-09-13 IL IL16075502A patent/IL160755A0/xx unknown
- 2002-09-13 PL PL369026A patent/PL213639B1/pl not_active IP Right Cessation
- 2002-09-13 AP APAP/P/2004/002982A patent/AP1818A/en active
2004
- 2004-03-04 IL IL160755A patent/IL160755A/en not_active IP Right Cessation
- 2004-03-10 NO NO20041003A patent/NO327009B1/no not_active IP Right Cessation
- 2004-03-12 MA MA27573A patent/MA26216A1/fr unknown
- 2004-11-30 HK HK04109442.1A patent/HK1066534A1/xx unknown
2008
- 2008-12-04 NO NO20085078A patent/NO20085078L/no unknown
- 2008-12-04 NO NO20085077A patent/NO20085077L/no not_active Application Discontinuation
2009
- 2009-03-19 CY CY20091100306T patent/CY1109449T1/el unknown
- 2009-12-08 JP JP2009278584A patent/JP2010100632A/ja active Pending

Also Published As

Publication number	Publication date
MXPA04002379A (es)	2004-05-31
AP2004002982A0 (en)	2004-03-31
KR20100082390A (ko)	2010-07-16
JP4463552B2 (ja)	2010-05-19
HUP0401923A3 (en)	2012-09-28
EP1425277A2 (fr)	2004-06-09
KR20040041610A (ko)	2004-05-17
NO327009B1 (no)	2009-04-06
OA12659A (en)	2006-06-19
IL160755A (en)	2009-09-01
HUP0401923A2 (hu)	2005-01-28
IL160755A0 (en)	2004-08-31
CN1553905A (zh)	2004-12-08
AP1818A (en)	2008-01-07
EA200400432A1 (ru)	2004-12-30
EP2298757A2 (fr)	2011-03-23
PL369026A1 (en)	2005-04-18
AU2002329397B2 (en)	2006-04-27
CA2458632A1 (fr)	2003-03-20
CY1109449T1 (el)	2014-08-13
MY138086A (en)	2009-04-30
TWI283665B (en)	2007-07-11
KR20090026369A (ko)	2009-03-12
US8063078B2 (en)	2011-11-22
DK1425277T3 (da)	2009-03-16
PT1425277E (pt)	2009-03-05
US20090163506A1 (en)	2009-06-25
EP2298757A3 (fr)	2011-12-28
KR101063679B1 (ko)	2011-09-07
SI1425277T1 (sl)	2009-04-30
EP2036902A3 (fr)	2009-05-06
BR0212468A (pt)	2004-10-19
JP2005504074A (ja)	2005-02-10
NO20041003L (no)	2004-06-04
WO2003022809A3 (fr)	2003-07-17
JP2010100632A (ja)	2010-05-06
KR100955967B1 (ko)	2010-05-04
WO2003022809A2 (fr)	2003-03-20
DE60230773D1 (de)	2009-02-26
AR038786A1 (es)	2005-01-26
ATE420083T1 (de)	2009-01-15
HK1066534A1 (en)	2005-03-24
PE20030417A1 (es)	2003-08-06
NO20085078L (no)	2004-06-04
EP1425277B1 (fr)	2009-01-07
UY27446A1 (es)	2003-04-30
ES2316607T3 (es)	2009-04-16
NZ531137A (en)	2006-08-31
CA2458632C (fr)	2011-08-23
EP1425277B8 (fr)	2009-04-01
NO20085077L (no)	2004-06-04
EP2036902A2 (fr)	2009-03-18
CN1247568C (zh)	2006-03-29
PL213639B1 (pl)	2013-04-30
EA007731B1 (ru)	2006-12-29

Publication	Publication Date	Title
MA26216A1 (fr)	2004-07-01	Nouveaux composes
MA27105A1 (fr)	2004-12-20	Nouveaux composes
NO20034026D0 (no)	2003-09-11	Nytt preparat
ATE402148T1 (de)	2008-08-15	Substituierte pyridinylamine
DE60230376D1 (de)	2009-01-29	Zweirad
DK1421841T3 (da)	2007-12-17	Mejetærsker
ATE524462T1 (de)	2011-09-15	C5-modifizierte indazolylpyrrolotriazine
DE50103741D1 (de)	2004-10-28	Welle-Nabe-Verbindung
DE10292917D2 (de)	2004-07-22	Fahrrad
DE50206892D1 (de)	2006-06-29	Substituierte imidazotriazinone
ATE335486T1 (de)	2006-09-15	Hydrazono-malonitrile
NO20034695L (no)	2003-12-03	Nytt preparat
DK1373228T3 (da)	2008-08-04	Substituerede fluoralkoxyphenylsulfonylurinstoffer
ITMI20020275V0 (it)	2002-05-27	Bicicletta
ATE355059T1 (de)	2006-03-15	Isoxazolopyridinone
DE50213651D1 (de)	2009-08-13	Substituierte 4-aminocyclohexanole
DE50201862D1 (de)	2005-01-27	Messwandler
MA25651A1 (fr)	2002-12-31	Composes caldilytiques
FI20010129A0 (fi)	2001-01-22	Kaksiviiraformeri
ATE319694T1 (de)	2006-03-15	Phenylalkyne
ATA18372001A (de)	2005-07-15	Gelenksbolzenbaueinheit
ATA13992002A (de)	2003-10-15	Schlackengranulierungsanlage
DE60110464D1 (de)	2005-06-02	Federball
DE50108381D1 (de)	2006-01-19	Synchronisierschaltungsanordnung
DE10295006D2 (de)	2004-10-07	Bauwerksabdichtung